Peptide GuideRetatrutide

The Peptide Guide

All weight & metabolic peptides

Retatrutide

AppetiteWeight

Retatrutide is a triple agonist of the GLP-1, GIP, and glucagon receptors, studied extensively for appetite control, energy expenditure, and substantial weight-loss research.

What does it do?

Lowers appetite so you get full faster and snack less
Slows how quickly the stomach empties, which helps portions stay smaller
Improves blood sugar and insulin handling
Increases energy use through its glucagon activity
Supports large, gradual fat loss when diet stays consistent
Can improve metabolic markers tied to weight, like waist size and glucose control

How does it work?

Activates GLP-1 receptors to reduce hunger and slow stomach emptying
Activates GIP receptors to support insulin response and appetite control
Activates glucagon receptors to help the body burn more energy
The three signals together produce stronger weight-loss effects than GLP-1 alone
Works as a long-acting weekly peptide, so the effect stays steady between doses

What to expect?

Meals feel satisfying sooner so you naturally stop earlier
Snacking loses its pull and random hunger gets quieter
Your stomach can feel a little off when the dose increases
That unsettled feeling usually settles after a couple of weeks at the new dose
Weight loss feels slow and steady rather than sudden
Clothes start fitting easier before the number on the scale makes a big move

How it's typically administered

Sub-Q injectionSubcutaneous injectiononce weekly; pre-filled pens are used in clinical trials

How it's typically dosed

Most common dose8–12 mg
FrequencyOnce weekly
Cycle durationOngoing, with a 12–20 week ramp-up before maintenance

BackAll weight & metabolic peptides Full peptide list